US Patent

US11160786 — Rapid disperse dosage form

Formulation · Assigned to Aprecia Pharmaceuticals LLC · Expires 2034-03-14 · 8y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

Aprecia Pharmaceuticals LLC has patented a method for making a rapidly dispersing dosage form of a water-soluble drug that dissolves in under 15 seconds.

USPTO Abstract

A high dose rapidly dispersing three-dimensionally printed dosage form comprising a high dose of water soluble drug in a porous matrix that disperses in water within a period of less than about 15 seconds is disclosed. Also disclosed are methods of preparing the dosage form and of treating a condition, disease or disorder that is therapeutically responsive to the drug.

Drugs covered by this patent

Patent Metadata

Patent number
US11160786
Jurisdiction
US
Classification
Formulation
Expires
2034-03-14
Drug substance claim
No
Drug product claim
Yes
Assignee
Aprecia Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.